Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Conatus Endures Another NASH Setback With Failure To Hit Fibrosis Endpoint

Mar 21 2019

• By Joseph Haas

liver

Related Content

Conatus' Liver Focus Goes Well Beyond NASH

Nov 30 2015

Combination Strategies A Common Thread In NASH R&D

Nov 21 2016

In NASH, Gilead Swung For The Fences And Struck Out Again

Feb 12 2019

Intercept Retakes The Lead In NASH

Feb 19 2019

In NASH Race, Bad News For Conatus, Good News For Genfit In PBC

Dec 10 2018

In Novartis, Conatus Lands Experienced, Deep-Pocketed NASH Partner

Dec 20 2016

Related Companies

Conatus Pharmaceuticals Inc.

Novartis AG

Intercept Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Genfit SA

Allergan plc

Additional Topics

Clinical Trials Research & Development Companies Liver & Hepatic BioPharmaceutical

More from Alimentary/Metabolic

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window